![]() |
Code of Federal Regulations (Last Updated: July 5, 2024) |
![]() |
Title 21 - Food and Drugs |
![]() |
Chapter I - Food and Drug Administration, Department of Health and Human Services |
![]() |
SubChapter D - Drugs for Human Use |
![]() |
Part 312 - Investigational New Drug Application |
![]() |
Subpart E - Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses |
§ 312.80 - Purpose. |
§ 312.81 - Scope. |
§ 312.82 - Early consultation. |
§ 312.83 - Treatment protocols. |
§ 312.84 - Risk-benefit analysis in review of marketing applications for drugs to treat life-threatening and severely-debilitating illnesses. |
§ 312.85 - Phase 4 studies. |
§ 312.86 - Focused FDA regulatory research. |
§ 312.87 - Active monitoring of conduct and evaluation of clinical trials. |
§ 312.88 - Safeguards for patient safety. |